Paradigm Biocapital Advisors LP - 27 Jan 2025 SCHEDULE 13G Report for Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: EWTX
Shares outstanding: 94.8M shares
Disclosed Ownership: 4.74M shares
Ownership: 5%
Form type: SCHEDULE 13G
Filing time: 03 Feb 2025, 16:36:27 UTC
Date of event: 27 Jan 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	5%	4.74M	4.74M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	5%	4.74M	4.74M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	5%	4.74M	4.74M	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	4.4%	4.18M	4.18M	/s/ David K. Kim	David K. Kim / Authorized Signatory